Conditions: Infectious Skin Diseases Bacterial Skin Diseases Staphylococcal Skin Infections Streptococcal Infections Abscess
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 150
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the efficacy, safety and tolerability of RX-1741, an oxazolidinone, versus linezolid, another oxazolidinone, in the treatment of uncomplicated skin and skin structure infections

Detailed description:

Arms:
arm 1: Radezolid 450 mg PO QD arm 2: Radezolid 450 mg PO BID arm 3: Linezolid 600 mg PO BID

Interventions: intervention 1: Radezolid intervention 2: Radezolid intervention 3: Linezolid
Intervention descriptions: intervention 1: 450mg PO QD intervention 2: 450mg PO BID intervention 3: 600mg PO BID

Protocol document: